Announcement of the Advisory Panel on Outreach and Education (APOE) July 28, 2021 Virtual Meeting, 36749-36751 [2021-14830]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 131 / Tuesday, July 13, 2021 / Notices
jbell on DSKJLSW7X2PROD with NOTICES
and (II) full Technical Report and
Appendixes.
The purpose of the public comment
period is to obtain comments on the
draft report. Comments are being sought
from individuals including scientists
and representatives from various
government agencies, industry, labor,
and other stakeholders, and also the
public. If there are errors of fact,
unsubstantiated claims, evidence of
careless experimental work, inclusion of
too much information already in the
literature, or statements that are
inaccurate, please note such in your
review comments.
The authors ask that special emphasis
be placed on technical review of the
following issues:
1. Does the draft document adequately
describe the process for gathering and
evaluating the information available on
occupational exposure limits or bands
for engineered nanomaterials?
2. Does the draft document adequately
describe the development of a
framework for categorizing engineered
nanomaterials by potential occupational
health hazard from inhalation exposure?
3. Are the clustering and classification
modeling methodologies reasonable for
these data?
4. Is a revision to current occupational
exposure banding guidance needed to
incorporate a band F?
5. How useful and practical is the
approach described in both the user
guide and full technical report for
deriving categorical occupational
exposure limits, and what are the
opportunities for improvement?
6. Are the current searches and
collection of scientific data sufficient,
and are there additional opportunities
for obtaining data that were not
included?
7. Would the methods used in the
report also be appropriate for a future
comprehensive dataset of experimental,
toxicological, and physicochemical
information for engineered
nanomaterials?
8. Are there additional comments that
you would like to provide?
John J. Howard,
Director, National Institute for Occupational
Safety and Health, Centers for Disease Control
and Prevention.
[FR Doc. 2021–14801 Filed 7–12–21; 8:45 am]
BILLING CODE 4163–18–P
VerDate Sep<11>2014
17:47 Jul 12, 2021
Jkt 253001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–7063–N]
Announcement of the Advisory Panel
on Outreach and Education (APOE)
July 28, 2021 Virtual Meeting
Centers for Medicare &
Medicaid Services (CMS), Health and
Human Services (HHS).
ACTION: Notice.
AGENCY:
This notice announces the
next meeting of the APOE (the Panel) in
accordance with the Federal Advisory
Committee Act. The Panel advises and
makes recommendations to the
Secretary of the U.S. Department of
Health and Human Services (HHS) (the
Secretary) and the Administrator of the
Centers for Medicare & Medicaid
Services (CMS) on opportunities to
enhance the effectiveness of consumer
education strategies concerning the
Health Insurance Marketplace®,
Medicare, Medicaid, and the Children’s
Health Insurance Program (CHIP). This
meeting is open to the public.
DATES:
Meeting Date: Wednesday, July 28,
2021 from 12:00 p.m. to 5:00 p.m.
eastern daylight time (e.d.t).
Deadline for Meeting Registration,
Presentations, Special
Accommodations, and Comments:
Wednesday, July 14, 2021, 5:00 p.m.
(e.d.t).
SUMMARY:
ADDRESSES:
Meeting Location: Virtual. All those
who RSVP will receive the link to
attend.
Presentations and Written Comments:
Presentations and written comments
should be submitted to: Lisa Carr,
Designated Federal Official (DFO),
Office of Communications, Centers for
Medicare & Medicaid Services, 200
Independence Avenue SW, Mailstop
325G HHH, Washington, DC 20201,
202–690–5742, or via email at APOE@
cms.hhs.gov.
Registration: The meeting is open to
the public, but attendance is limited to
the space available. Persons wishing to
attend this meeting must register at the
website https://www.eventbrite.com/e/
apoe-july-28-2021-virtual-meetingtickets-151112584809 or by contacting
the DFO listed in the FOR FURTHER
INFORMATION CONTACT section of this
notice, by the date listed in the DATES
section of this notice. Individuals
requiring sign language interpretation or
other special accommodations should
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
36749
contact the DFO at the address listed in
the ADDRESSES section of this notice by
the date listed in the DATES section of
this notice.
FOR FURTHER INFORMATION CONTACT: Lisa
Carr, Designated Federal Official, Office
of Communications, 200 Independence
Avenue SW, Mailstop 325G HHH,
Washington, DC 20201, 202–690–5742,
or via email at APOE@cms.hhs.gov.
Additional information about the
APOE is available at: https://
www.cms.gov/Regulations-andGuidance/Guidance/FACA/APOE. Press
inquiries are handled through the CMS
Press Office at (202) 690–6145.
SUPPLEMENTARY INFORMATION:
I. Background and Charter Renewal
Information
A. Background
The Advisory Panel for Outreach and
Education (APOE) (the Panel) is
governed by the provisions of the
Federal Advisory Committee Act
(FACA) (Pub. L. 92–463), as amended (5
U.S.C. Appendix 2), which sets forth
standards for the formation and use of
federal advisory committees. The Panel
is authorized by section 1114(f) of the
Social Security Act (the Act) (42 U.S.C.
1314(f)) and section 222 of the Public
Health Service Act (42 U.S.C. 217a).
The Secretary of the U.S. Department
of Health and Human Services (HHS)
(the Secretary) signed the charter
establishing the Citizen’s Advisory
Panel on Medicare Education 1 (the
predecessor to the APOE) on January 21,
1999 (64 FR 7899) to advise and make
recommendations to the Secretary and
the Administrator of the Centers for
Medicare & Medicaid Services (CMS) on
the effective implementation of national
Medicare education programs, including
with respect to the Medicare+Choice
(M+C) program added by the Balanced
Budget Act of 1997 (Pub. L. 105–33).
The Medicare Prescription Drug,
Improvement, and Modernization Act of
2003 (MMA) (Pub. L. 108–173)
expanded the existing health plan
options and benefits available under the
M+C program and renamed it the
Medicare Advantage (MA) program.
CMS has had substantial responsibilities
to provide information to Medicare
beneficiaries about the range of health
plan options available and better tools
to evaluate these options. The
successful MA program implementation
required CMS to consider the views and
policy input from a variety of private
1 We note that the Citizen’s Advisory Panel on
Medicare Education is also referred to as the
Advisory Panel on Medicare Education (65 FR
4617). The name was updated in the Second
Amended Charter approved on July 24, 2000.
E:\FR\FM\13JYN1.SGM
13JYN1
jbell on DSKJLSW7X2PROD with NOTICES
36750
Federal Register / Vol. 86, No. 131 / Tuesday, July 13, 2021 / Notices
sector constituents and to develop a
broad range of public-private
partnerships.
In addition, Title I of the MMA
authorized the Secretary and the
Administrator of CMS (by delegation) to
establish the Medicare prescription drug
benefit. The drug benefit allows
beneficiaries to obtain qualified
prescription drug coverage. In order to
effectively administer the MA program
and the Medicare prescription drug
benefit, we have substantial
responsibilities to provide information
to Medicare beneficiaries about the
range of health plan options and
benefits available, and to develop better
tools to evaluate these plans and
benefits.
The Patient Protection and Affordable
Care Act (Pub. L. 111–148) and Health
Care and Education Reconciliation Act
of 2010 (Pub. L. 111–152) (collectively
referred to as the Affordable Care Act)
expanded the availability of other
options for health care coverage and
enacted a number of changes to
Medicare as well as to Medicaid and
CHIP. Qualified individuals and
qualified employers are now able to
purchase private health insurance
coverage through a competitive
marketplace, called an Affordable
Insurance Exchange (also called Health
Insurance Marketplace®, or
Marketplace® 2). In order to effectively
implement and administer these
changes, we must provide information
to consumers, providers, and other
stakeholders through education and
outreach programs regarding how
existing programs will change and the
expanded range of health coverage
options available, including private
health insurance coverage through the
Marketplace®. The APOE (the Panel)
allows us to consider a broad range of
views and information from interested
audiences in connection with this effort
and to identify opportunities to enhance
the effectiveness of education strategies
concerning the Affordable Care Act.
The scope of this Panel also includes
advising on issues pertaining to the
education of providers and stakeholders
with respect to the Affordable Care Act
and certain provisions of the Health
Information Technology for Economic
and Clinical Health (HITECH) Act
enacted as part of the American
Recovery and Reinvestment Act of 2009
(ARRA) (Pub. L. 111–5).
On January 21, 2011, the Panel’s
charter was renewed and the Panel was
renamed the Advisory Panel for
2 Health Insurance Marketplace®SM and
Marketplace®SM are service marks of the U.S.
Department of Health and Human Services.
VerDate Sep<11>2014
17:47 Jul 12, 2021
Jkt 253001
Outreach and Education. The Panel’s
charter was most recently renewed on
January 19, 2021, and will terminate on
January 19, 2023 unless renewed by
appropriate action.
B. Charter Renewal
In accordance with the January 19,
2021, charter, the APOE will advise the
HHS and CMS on developing and
implementing education programs that
support individuals who are enrolled in
or eligible for Medicare, Medicaid,
CHIP, or coverage available through the
Health Insurance Marketplace® and
other CMS programs. The scope of this
FACA group also includes advising on
education of providers and stakeholders
with respect to health care reform and
certain provisions of the HITECH Act
enacted as part of the ARRA.
The charter will terminate on January
19, 2023, unless renewed by appropriate
action. The APOE was chartered under
42 U.S.C. 217a, section 222 of the Public
Health Service Act, as amended. The
APOE is governed by provisions of
Public Law 92–463, as amended (5
U.S.C. Appendix 2), which sets forth
standards for the formation and use of
advisory committees.
In accordance with the renewed
charter, the APOE will advise the
Secretary and the CMS Administrator
concerning optimal strategies for the
following:
• Developing and implementing
education and outreach programs for
individuals enrolled in, or eligible for,
Medicare, Medicaid, the CHIP, and
coverage available through the Health
Insurance Marketplace® and other CMS
programs.
• Enhancing the federal government’s
effectiveness in informing Medicare,
Medicaid, CHIP, or the Health Insurance
Marketplace® consumers, issuers,
providers, and stakeholders, pursuant to
education and outreach programs of
issues regarding these programs,
including the appropriate use of publicprivate partnerships to leverage the
resources of the private sector in
educating beneficiaries, providers,
partners and stakeholders.
• Expanding outreach to vulnerable
and underserved communities,
including racial and ethnic minorities,
in the context of Medicare, Medicaid,
the CHIP and the Health Insurance
Marketplace® education programs, and
other CMS programs as designated.
• Assembling and sharing an
information base of ‘‘best practices’’ for
helping consumers evaluate health
coverage options.
• Building and leveraging existing
community infrastructures for
information, counseling, and assistance.
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
• Drawing the program link between
outreach and education, promoting
consumer understanding of health care
coverage choices, and facilitating
consumer selection/enrollment, which
in turn support the overarching goal of
improved access to quality care,
including prevention services,
envisioned under the Affordable Care
Act.
The current members of the Panel as
of June 3, 2021, are: E. Lorraine Bell,
Chief Officer, Population Health,
Catholic Charities USA; Nazleen
Bharmal, Medical Director of
Community Partnerships, Cleveland
Clinic; Julie Carter, Senior Federal
Policy Associate, Medicare Rights
Center; Scott Ferguson, Director of Care
Transitions and Population Health,
Mount Sinai St. Luke’s Hospital; Leslie
Fried, Senior Director, Center for
Benefits Access, National Council on
Aging; Jean-Venable Robertson Goode,
Professor, Department of
Pharmacotherapy and Outcomes
Science, School of Pharmacy, Virginia
Commonwealth University; Ted
Henson, Director of Health Center
Performance and Innovation, National
Association of Community Health
Centers; Joan Ilardo, Director of
Research Initiatives, Michigan State
University, College of Human Medicine;
Cheri Lattimer, Executive Director,
National Transitions of Care Coalition;
Cori McMahon, Vice President,
Tridiuum; Alan Meade, Director of
Rehabilitation Services, Holston
Medical Group; Michael Minor,
National Director, H.O.P.E. HHS
Partnership, National Baptist
Convention USA, Incorporated; Jina
Ragland, Associate State Director of
Advocacy and Outreach, AARP
Nebraska; Morgan Reed, Executive
Director, Association for Competitive
Technology; Margot Savoy, Chair,
Department of Family and Community
Medicine, Temple University
Physicians; Congresswoman Allyson
Schwartz, President and CEO, Better
Medicare Alliance; and; Tia Whitaker,
Statewide Director, Outreach and
Enrollment, Pennsylvania Association
of Community Health Centers.
II. Provisions of This Notice
In accordance with section 10(a) of
the FACA, this notice announces a
meeting of the APOE. The agenda for
the July 28, 2021 meeting will include
the following:
• Welcome and listening session with
CMS leadership
• Recap of the previous (May 26, 2021)
meeting
• CMS programs, initiatives, and
priorities
E:\FR\FM\13JYN1.SGM
13JYN1
Federal Register / Vol. 86, No. 131 / Tuesday, July 13, 2021 / Notices
• An opportunity for public comment
• Meeting summary, review of
recommendations, and next steps
Individuals or organizations that wish
to make a 5-minute oral presentation on
an agenda topic should submit a written
copy of the oral presentation to the DFO
at the address listed in the ADDRESSES
section of this notice by the date listed
in the DATES section of this notice. The
number of oral presentations may be
limited by the time available.
Individuals not wishing to make an oral
presentation may submit written
comments to the DFO at the address
listed in the ADDRESSES section of this
notice by the date listed in the DATES
section of this notice.
III. Meeting Participation
The meeting is open to the public, but
attendance is limited to registered
participants. Persons wishing to attend
this meeting must register at the website
https://www.eventbrite.com/e/apoe-july28-2021-virtual-meeting-tickets151112584809 or contact the DFO at the
address or number listed in the FOR
FURTHER INFORMATION CONTACT section of
this notice by the date specified in the
DATES section of this notice. This
meeting will be held virtually.
Individuals who are not registered in
advance will be unable to attend the
meeting.
IV. Collection of Information
jbell on DSKJLSW7X2PROD with NOTICES
This document does not impose
information collection requirements,
that is, reporting, recordkeeping, or
third-party disclosure requirements.
Consequently, there is no need for
review by the Office of Management and
Budget under the authority of the
Paperwork Reduction Act of 1995 (44
U.S.C. Chapter 35).
The Administrator of the Centers for
Medicare & Medicaid Services (CMS),
Chiquita Brooks-LaSure, having
reviewed and approved this document,
authorizes Lynette Wilson, who is the
Federal Register Liaison, to
electronically sign this document for
purposes of publication in the Federal
Register.
Dated: June 30, 2021.
Lynette Wilson,
Federal Register Liaison, Centers for Medicare
& Medicaid Services.
[FR Doc. 2021–14830 Filed 7–12–21; 8:45 am]
BILLING CODE 4120–01–P
VerDate Sep<11>2014
17:47 Jul 12, 2021
Jkt 253001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–2567]
Emergency Clearance: Public
Information Collection Requirements
Submitted to the Office of Management
and Budget (OMB)
Centers for Medicare &
Medicaid Services, Health and Human
Services.
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is requesting
that this information collection request
(ICR), for revisions to the form CMS–
2567 be processed under the emergency
Paperwork Reduction Act of 1995 (PRA)
clearance process.
DATES: Comments must be received by
August 12, 2021.
ADDRESSES: When commenting, please
reference the document identifier
(CMS–2567) or OMB control number
(0938–0391). To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: CMS–R–39/OMB Control
Number 0938–0365, Room C4–26–05,
7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ website address at
https://www.cms.hhs.gov/
PaperworkReductionActof1995.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
William Parham, Reports Clearance
Office at (410) 786–1326.
SUPPLEMENTARY INFORMATION: In
December, 2020, Congress passed the
Consolidated Appropriations Act, 2021
(CAA, 2021). Section 407 of CAA, 2021,
amended Part A of Title XVIII of the
Social Security Act (the Act) at section
1822 establishing hospice program
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
36751
survey and enforcement requirements.
This amendment, in part, now requires
the Accrediting Organizations (AOs)
that accredit hospice programs to
include the form CMS–2567 to
document the findings of their hospice
program surveys beginning on October
1, 2021. Public harm is reasonably likely
to ensue if the normal, non-emergency
clearance procedures are followed. CMS
would miss the statutorily mandated
deadline of October 1, 2021 for
Accrediting Organizations (AOs), with a
hospice program, to begin using the
form CMS–2567. AOs will not have the
revised form to include in their current
survey documentation systems and
processes and will not meet the
deadline of October 1, 2021 for
beginning use. If CMS misses the
deadline, it will jeopardize another
CAA, 2021 mandated provision
deadline for public posting of these AO
hospice program survey reports on our
website. The purpose of this
requirement is for public transparency
of survey and certification information.
This statutory provision requires that
the hospice program survey reports be
posted by no later than October 1, 2022.
Additionally, the public may not have
all the information necessary to make an
informed decision regarding where they
seek high quality, safe care hospice
program organizations for themselves or
loved ones. Beneficiaries and the public
at large utilize survey findings when
evaluating whether to receive care from
certain facilities.
Under the PRA, federal agencies are
required to publish notice in the
Federal Register concerning each
proposed ICR. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this ICR including the necessity and
utility of the proposed ICR for the
proper performance of the agency’s
functions, the accuracy of the estimated
burden, ways to enhance the quality,
utility, and clarity of the information to
be collected and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
Contents
This notice sets out a summary of the
use and burden associated with the
following ICR. More detailed
information can be found in the
collection’s supporting statement and
associated materials (see ADDRESSES).
CMS–2567 Statement of Deficiency
and Plan of Correction
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
approval from the Office of Management
E:\FR\FM\13JYN1.SGM
13JYN1
]]>Agencies
[Federal Register Volume 86, Number 131 (Tuesday, July 13, 2021)]
[Notices]
[Pages 36749-36751]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-14830]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-7063-N]
Announcement of the Advisory Panel on Outreach and Education
(APOE) July 28, 2021 Virtual Meeting
AGENCY: Centers for Medicare & Medicaid Services (CMS), Health and
Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces the next meeting of the APOE (the Panel)
in accordance with the Federal Advisory Committee Act. The Panel
advises and makes recommendations to the Secretary of the U.S.
Department of Health and Human Services (HHS) (the Secretary) and the
Administrator of the Centers for Medicare & Medicaid Services (CMS) on
opportunities to enhance the effectiveness of consumer education
strategies concerning the Health Insurance Marketplace[supreg],
Medicare, Medicaid, and the Children's Health Insurance Program (CHIP).
This meeting is open to the public.
DATES:
Meeting Date: Wednesday, July 28, 2021 from 12:00 p.m. to 5:00 p.m.
eastern daylight time (e.d.t).
Deadline for Meeting Registration, Presentations, Special
Accommodations, and Comments: Wednesday, July 14, 2021, 5:00 p.m.
(e.d.t).
ADDRESSES:
Meeting Location: Virtual. All those who RSVP will receive the link
to attend.
Presentations and Written Comments: Presentations and written
comments should be submitted to: Lisa Carr, Designated Federal Official
(DFO), Office of Communications, Centers for Medicare & Medicaid
Services, 200 Independence Avenue SW, Mailstop 325G HHH, Washington, DC
20201, 202-690-5742, or via email at [email protected].
Registration: The meeting is open to the public, but attendance is
limited to the space available. Persons wishing to attend this meeting
must register at the website https://www.eventbrite.com/e/apoe-july-28-2021-virtual-meeting-tickets-151112584809 or by contacting the DFO
listed in the FOR FURTHER INFORMATION CONTACT section of this notice,
by the date listed in the DATES section of this notice. Individuals
requiring sign language interpretation or other special accommodations
should contact the DFO at the address listed in the ADDRESSES section
of this notice by the date listed in the DATES section of this notice.
FOR FURTHER INFORMATION CONTACT: Lisa Carr, Designated Federal
Official, Office of Communications, 200 Independence Avenue SW,
Mailstop 325G HHH, Washington, DC 20201, 202-690-5742, or via email at
[email protected].
Additional information about the APOE is available at: https://www.cms.gov/Regulations-and-Guidance/Guidance/FACA/APOE. Press
inquiries are handled through the CMS Press Office at (202) 690-6145.
SUPPLEMENTARY INFORMATION:
I. Background and Charter Renewal Information
A. Background
The Advisory Panel for Outreach and Education (APOE) (the Panel) is
governed by the provisions of the Federal Advisory Committee Act (FACA)
(Pub. L. 92-463), as amended (5 U.S.C. Appendix 2), which sets forth
standards for the formation and use of federal advisory committees. The
Panel is authorized by section 1114(f) of the Social Security Act (the
Act) (42 U.S.C. 1314(f)) and section 222 of the Public Health Service
Act (42 U.S.C. 217a).
The Secretary of the U.S. Department of Health and Human Services
(HHS) (the Secretary) signed the charter establishing the Citizen's
Advisory Panel on Medicare Education \1\ (the predecessor to the APOE)
on January 21, 1999 (64 FR 7899) to advise and make recommendations to
the Secretary and the Administrator of the Centers for Medicare &
Medicaid Services (CMS) on the effective implementation of national
Medicare education programs, including with respect to the
Medicare+Choice (M+C) program added by the Balanced Budget Act of 1997
(Pub. L. 105-33).
---------------------------------------------------------------------------
\1\ We note that the Citizen's Advisory Panel on Medicare
Education is also referred to as the Advisory Panel on Medicare
Education (65 FR 4617). The name was updated in the Second Amended
Charter approved on July 24, 2000.
---------------------------------------------------------------------------
The Medicare Prescription Drug, Improvement, and Modernization Act
of 2003 (MMA) (Pub. L. 108-173) expanded the existing health plan
options and benefits available under the M+C program and renamed it the
Medicare Advantage (MA) program. CMS has had substantial
responsibilities to provide information to Medicare beneficiaries about
the range of health plan options available and better tools to evaluate
these options. The successful MA program implementation required CMS to
consider the views and policy input from a variety of private
[[Page 36750]]
sector constituents and to develop a broad range of public-private
partnerships.
In addition, Title I of the MMA authorized the Secretary and the
Administrator of CMS (by delegation) to establish the Medicare
prescription drug benefit. The drug benefit allows beneficiaries to
obtain qualified prescription drug coverage. In order to effectively
administer the MA program and the Medicare prescription drug benefit,
we have substantial responsibilities to provide information to Medicare
beneficiaries about the range of health plan options and benefits
available, and to develop better tools to evaluate these plans and
benefits.
The Patient Protection and Affordable Care Act (Pub. L. 111-148)
and Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-
152) (collectively referred to as the Affordable Care Act) expanded the
availability of other options for health care coverage and enacted a
number of changes to Medicare as well as to Medicaid and CHIP.
Qualified individuals and qualified employers are now able to purchase
private health insurance coverage through a competitive marketplace,
called an Affordable Insurance Exchange (also called Health Insurance
Marketplace[supreg], or Marketplace[supreg] \2\). In order to
effectively implement and administer these changes, we must provide
information to consumers, providers, and other stakeholders through
education and outreach programs regarding how existing programs will
change and the expanded range of health coverage options available,
including private health insurance coverage through the
Marketplace[supreg]. The APOE (the Panel) allows us to consider a broad
range of views and information from interested audiences in connection
with this effort and to identify opportunities to enhance the
effectiveness of education strategies concerning the Affordable Care
Act.
---------------------------------------------------------------------------
\2\ Health Insurance Marketplace[supreg]SM and
Marketplace[supreg]SM are service marks of the U.S.
Department of Health and Human Services.
---------------------------------------------------------------------------
The scope of this Panel also includes advising on issues pertaining
to the education of providers and stakeholders with respect to the
Affordable Care Act and certain provisions of the Health Information
Technology for Economic and Clinical Health (HITECH) Act enacted as
part of the American Recovery and Reinvestment Act of 2009 (ARRA) (Pub.
L. 111-5).
On January 21, 2011, the Panel's charter was renewed and the Panel
was renamed the Advisory Panel for Outreach and Education. The Panel's
charter was most recently renewed on January 19, 2021, and will
terminate on January 19, 2023 unless renewed by appropriate action.
B. Charter Renewal
In accordance with the January 19, 2021, charter, the APOE will
advise the HHS and CMS on developing and implementing education
programs that support individuals who are enrolled in or eligible for
Medicare, Medicaid, CHIP, or coverage available through the Health
Insurance Marketplace[supreg] and other CMS programs. The scope of this
FACA group also includes advising on education of providers and
stakeholders with respect to health care reform and certain provisions
of the HITECH Act enacted as part of the ARRA.
The charter will terminate on January 19, 2023, unless renewed by
appropriate action. The APOE was chartered under 42 U.S.C. 217a,
section 222 of the Public Health Service Act, as amended. The APOE is
governed by provisions of Public Law 92-463, as amended (5 U.S.C.
Appendix 2), which sets forth standards for the formation and use of
advisory committees.
In accordance with the renewed charter, the APOE will advise the
Secretary and the CMS Administrator concerning optimal strategies for
the following:
Developing and implementing education and outreach
programs for individuals enrolled in, or eligible for, Medicare,
Medicaid, the CHIP, and coverage available through the Health Insurance
Marketplace[supreg] and other CMS programs.
Enhancing the federal government's effectiveness in
informing Medicare, Medicaid, CHIP, or the Health Insurance
Marketplace[supreg] consumers, issuers, providers, and stakeholders,
pursuant to education and outreach programs of issues regarding these
programs, including the appropriate use of public-private partnerships
to leverage the resources of the private sector in educating
beneficiaries, providers, partners and stakeholders.
Expanding outreach to vulnerable and underserved
communities, including racial and ethnic minorities, in the context of
Medicare, Medicaid, the CHIP and the Health Insurance
Marketplace[supreg] education programs, and other CMS programs as
designated.
Assembling and sharing an information base of ``best
practices'' for helping consumers evaluate health coverage options.
Building and leveraging existing community infrastructures
for information, counseling, and assistance.
Drawing the program link between outreach and education,
promoting consumer understanding of health care coverage choices, and
facilitating consumer selection/enrollment, which in turn support the
overarching goal of improved access to quality care, including
prevention services, envisioned under the Affordable Care Act.
The current members of the Panel as of June 3, 2021, are: E.
Lorraine Bell, Chief Officer, Population Health, Catholic Charities
USA; Nazleen Bharmal, Medical Director of Community Partnerships,
Cleveland Clinic; Julie Carter, Senior Federal Policy Associate,
Medicare Rights Center; Scott Ferguson, Director of Care Transitions
and Population Health, Mount Sinai St. Luke's Hospital; Leslie Fried,
Senior Director, Center for Benefits Access, National Council on Aging;
Jean-Venable Robertson Goode, Professor, Department of Pharmacotherapy
and Outcomes Science, School of Pharmacy, Virginia Commonwealth
University; Ted Henson, Director of Health Center Performance and
Innovation, National Association of Community Health Centers; Joan
Ilardo, Director of Research Initiatives, Michigan State University,
College of Human Medicine; Cheri Lattimer, Executive Director, National
Transitions of Care Coalition; Cori McMahon, Vice President, Tridiuum;
Alan Meade, Director of Rehabilitation Services, Holston Medical Group;
Michael Minor, National Director, H.O.P.E. HHS Partnership, National
Baptist Convention USA, Incorporated; Jina Ragland, Associate State
Director of Advocacy and Outreach, AARP Nebraska; Morgan Reed,
Executive Director, Association for Competitive Technology; Margot
Savoy, Chair, Department of Family and Community Medicine, Temple
University Physicians; Congresswoman Allyson Schwartz, President and
CEO, Better Medicare Alliance; and; Tia Whitaker, Statewide Director,
Outreach and Enrollment, Pennsylvania Association of Community Health
Centers.
II. Provisions of This Notice
In accordance with section 10(a) of the FACA, this notice announces
a meeting of the APOE. The agenda for the July 28, 2021 meeting will
include the following:
Welcome and listening session with CMS leadership
Recap of the previous (May 26, 2021) meeting
CMS programs, initiatives, and priorities
[[Page 36751]]
An opportunity for public comment
Meeting summary, review of recommendations, and next steps
Individuals or organizations that wish to make a 5-minute oral
presentation on an agenda topic should submit a written copy of the
oral presentation to the DFO at the address listed in the ADDRESSES
section of this notice by the date listed in the DATES section of this
notice. The number of oral presentations may be limited by the time
available. Individuals not wishing to make an oral presentation may
submit written comments to the DFO at the address listed in the
ADDRESSES section of this notice by the date listed in the DATES
section of this notice.
III. Meeting Participation
The meeting is open to the public, but attendance is limited to
registered participants. Persons wishing to attend this meeting must
register at the website https://www.eventbrite.com/e/apoe-july-28-2021-virtual-meeting-tickets-151112584809 or contact the DFO at the address
or number listed in the FOR FURTHER INFORMATION CONTACT section of this
notice by the date specified in the DATES section of this notice. This
meeting will be held virtually. Individuals who are not registered in
advance will be unable to attend the meeting.
IV. Collection of Information
This document does not impose information collection requirements,
that is, reporting, recordkeeping, or third-party disclosure
requirements. Consequently, there is no need for review by the Office
of Management and Budget under the authority of the Paperwork Reduction
Act of 1995 (44 U.S.C. Chapter 35).
The Administrator of the Centers for Medicare & Medicaid Services
(CMS), Chiquita Brooks-LaSure, having reviewed and approved this
document, authorizes Lynette Wilson, who is the Federal Register
Liaison, to electronically sign this document for purposes of
publication in the Federal Register.
Dated: June 30, 2021.
Lynette Wilson,
Federal Register Liaison, Centers for Medicare & Medicaid Services.
[FR Doc. 2021-14830 Filed 7-12-21; 8:45 am]
BILLING CODE 4120-01-P
